Stepien, Olivier, and Pierre Marche. Amlodipine inhibits thapsigargin-sensitive Ca 2ϩ stores in thrombin-stimulated vascular smooth muscle cells. Am J Physiol Heart Circ Physiol 279: H1220-H1227, 2000.-Ca 2ϩ channel blockers, such as amlodipine, inhibit vascular smooth muscle cell (VSMC) growth through interactions with targets other than L-type Ca 2ϩ channels. The effects of amlodipine on Ca 2ϩ movements in thrombin-and thapsigargin-stimulated VSMCs were therefore investigated by determining the variations of intracellular free Ca 2ϩ concentration in fura 2-loaded cultured VSMCs. Results indicated that 10-1,000 nM amlodipine inhibited 1) thrombin-induced Ca 2ϩ mobilization from a thapsigargin-sensitive pool and 2) thapsigargin-induced Ca 2ϩ responses, including Ca 2ϩ mobilization from internal stores and store-operated Ca 2ϩ entry. These effects of amlodipine do not involve L-type Ca 2ϩ channels and could not be reproduced with 100 nM isradipine, diltiazem, or verapamil. The inhibition by amlodipine of Ca 2ϩ mobilization appears therefore to be a specific property of the drug, in addition to its Ca 2ϩ channel-blocking property. It is suggested that amlodipine acts in this capacity by interacting with Ca 2ϩ -ATPases of the sarcoplasmic reticulum, thus modulating the enzyme activity. This mechanism might participate in the inhibitory effect of amlodipine on VSMC growth. calcium channel blockers; calcium mobilization; vascular smooth muscle cell growth IT IS WELL RECOGNIZED that the proliferation of vascular smooth muscle cells (VSMCs) is a key event in the pathogenesis of various vascular diseases, including atherosclerosis and postangioplasty restenosis (32) . Among the factors that have been shown to be involved in the control of VSMC growth, thrombin appears to play an important role (24) . The mechanisms whereby thrombin induced VSMC growth/proliferation have been documented (6, 24) , and one of the most immediate signaling events has been demonstrated to be thrombin-evoked variations of intracellular free Ca 2ϩ concentration ([Ca 2ϩ ] i ) (1) . [Ca 2ϩ ] i variations play a predominant role in VSMC proliferation (27, 36) , and in this cell type the voltage-activated Ca 2ϩ channels considerably participate in intracellular Ca 2ϩ homeostasis (see Ref. 15 
for review).
There is compelling evidence that Ca 2ϩ channel blockers (CCBs) inhibit VSMC growth/proliferation (18) , but the mechanisms underlying this inhibitory effect of CCBs remain to be determined. Recent data are consistent with the idea that CCBs interact with targets other than the L-type Ca 2ϩ channel (4, 31) . Of the various CCBs, the L-type Ca 2ϩ channel antagonist amlodipine is of particular interest, because this dihydropyridine derivative endowed with antihypertensive and antiatherosclerotic properties exhibits a selectivity for the vasculature relative to the myocardium (7, 23, 29) . Moreover, recent results that described the inhibitory effect of amlodipine on thrombin-induced proliferation of VSMCs from rat aortas (39) suggested that, in addition to its L-type Ca 2ϩ channel inhibitory effect, amlodipine might inhibit other intracellular signaling pathways involved in VSMC proliferation.
This prompted us to investigate the influence of amlodipine on thrombin-elicited Ca 2ϩ movements in rat aortic VSMCs compared with that of other CCBs such as isradipine, diltiazem, and verapamil.
MATERIALS AND METHODS

Reagents.
Cell culture materials and media were obtained from Costar and Life Technologies, respectively; FCS was from Boehringer-Mannheim; thrombin and amlodipine were from Roche (Basel, Switzerland) and Pfizer (Orsay, France), respectively; and fura 2-AM was from Molecular Probes (Eugene, OR). All other chemicals, including the CCBs isradipine, diltiazem, and verapamil, were obtained from Sigma Chemical (St. Louis, MO).
Cells and culture conditions. VSMCs were isolated from the thoracic aortas of 10-wk-old Wistar-Kyoto rats by the explant technique of Ross (33), as previously described (13) . They were grown in DMEM supplemented with 8 mM HEPES buffer, 100 U/ml penicillin, 100 g/ml streptomycin, and 10% (vol/vol) FCS. Cells were subcultured weekly. Cells between passages 4 and 13 were used. VSMCs grew in a characteristic "hill-and-valley" pattern, and immunostaining procedures showed that cells were reactive to anti-␣-actin antibodies. For each experiment, VSMCs were cultured for 3 days in 10% FCS and then made quiescent by serum deprivation for 2 days. Cell viability was assessed by the measurement of lactate dehydrogenase activity released from damaged cells by use of the cytotoxic detection kit (Boehringer-Mannheim); it was not affected by the various experimental conditions used in these investigations.
[Ca 2ϩ ] i measurement. [Ca 2ϩ ] i was determined by using the fluorescent indicator fura 2. VSMCs were allowed to attach and grow on glass coverslips in 10% FCS-containing medium. Then VSMCs were rendered quiescent, as described above. On the day of the experiment, the coverslips were washed twice with modified Hanks' buffered saline solution (in mM: 135 NaCl, 5.4 KCl, 44 NaHCO 3 , 0.9 NaH 2 PO 4 , 10 HEPES, 0.8 MgSO 4 , and 5 glucose), pH 7.4, and kept at 37°C before incubation for 40 min in a humidified incubator at 37°C with fura 2-AM (3 M in DMSO containing 0.025% Pluronic F-127) for fluoroprobe loading. DMSO concentration was Ͻ0.1% and has no effect on [Ca 2ϩ ] i . Before each experiment, coverslips were washed with the modified Hanks' buffered saline solution for extracellular dye removal. Then they were inserted in a cuvette containing 3 ml of Ca 2ϩ -containing medium (i.e., the modified Hanks' buffered saline solution with 1 mM CaCl 2 ) or Ca 2ϩ -free medium [i.e., a modified EGTA-containing Hanks' buffered saline solution (17) ] and the various agents to be tested. Fluorescence was monitored at 510 nm (excitations were at 340 and 380 nm) with a dual-excitation-wavelength spectrofluorometer (SPEX fluorolog, Jobin-Yvon, Longjumeau, France) equipped with a chamber thermostatically controlled at 37°C. After a stable basal value was monitored, cells were exposed to the agent(s) to be tested. Autofluorescence from unloaded cells and test agent(s) was subtracted from the measured value. [Ca 2ϩ ] i was calculated using the equation of Grynkiewicz et al. (11) .
Statistical analysis. Values are means Ϯ SE of n experiments. Each experiment involved one distinct culture. Multiple comparisons and dose-response and time-dependence effects were examined by one-way ANOVA and post hoc Fisher's test. Unless otherwise stated, tests of significance were performed using the unpaired Student's t-test. ] i responses to various doses of thrombin reached a maximum for thrombin concentration of 0.5-1 U/ml (results not shown). Therefore, further experiments were carried out with 1 U/ml thrombin. Figure 1A shows that thrombin-induced [Ca 2ϩ ] i variations considerably depended on the presence of Ca 2ϩ in the external medium. In Ca 2ϩ -containing medium, thrombin elicited an initial transient peak followed by a sustained phase, whereas in Ca 2ϩ -free medium, the [Ca 2ϩ ] i response consisted only in the transient peak (Fig. 1A, traces a  and b) . A quantitative analysis of data revealed that, irrespective of the presence of Ca 2ϩ in the external medium, [Ca 2ϩ ] i values at basal (before stimulation) and at peak levels did not differ significantly ( Table 1) .
RESULTS
Assessment of thrombin-induced [
The origin of internal Ca 2ϩ pool mobilized, i.e., released, by thrombin was further examined in cells pretreated with thapsigargin, a highly lipophilic sesquiterpene ␥-lactone that mobilizes intracellular Ca 2ϩ by selectively inhibiting sarco(endo)plasmic reticulum Ca 2ϩ -dependent ATPases (SERCAs) (40) . When VSMCs were preincubated for 20 min with thapsigargin (1 M), [Ca 2ϩ ] i elevation elicited by thrombin in a Ca 2ϩ -containing medium consisted only in the sustained phase that reached a plateau after ϳ200 s (Fig.   1B , trace b). This suggested that the thapsigarginsensitive sarcoplasmic reticulum Ca 2ϩ store was the intracellular source for the thrombin-induced Ca 2ϩ signal observed in Ca 2ϩ -free medium. Such a hypothesis was supported by experiments performed in Ca 2ϩ -free medium and in which VSMCs were treated for 8-10 min by thapsigargin before thrombin stimulation. Under this experimental condition, thrombin was no longer capable of elevating [Ca 2ϩ ] i (Fig. 1C ). This finding supported the hypothesis that the thrombin-induced transient increase in [Ca 2ϩ ] i resulted from the mobilization, i.e., release, of thapsigargin-sensitive intracellular Ca 2ϩ stores. 
Effects of amlodipine on voltage-operated Ca
2ϩ channels. In a first series of experiments, we ascertained that cultured VSMCs used in our investigations expressed functional dihydropyridine-sensitive voltageoperated Ca 2ϩ channels. To do so, cells were pretreated with amlodipine or its diluent (for control) and then depolarized by the addition of a high (80 mM) KCl concentration to the medium. Under these experimental conditions, addition of KCl to control cells produced a transient elevation in [Ca 2ϩ ] i (⌬ [Ca 2ϩ ] i ϳ300 nM) followed by a sustained increase (Fig. 2) . When VSMCs were pretreated with 10 nM amlodipine, the Ca 2ϩ response to KCl addition decreased in a time-dependent manner. After 10 and 60 min of pretreatment with the drug, the KCl-induced increase in [Ca 2ϩ ] i was 95 Ϯ 3 and 40 Ϯ 6% of controls (n ϭ 3-6; not shown); preincubation of VSMCs for 2 h with amlodipine abolished the Ca 2ϩ response to KCl (Fig. 2 ), in agreement with preceding reports (23, 38) . Thus, unless otherwise specified, in the following experiments, VSMCs were pretreated with amlodipine for 2 h. ] i elevation was diminished by amlodipine in a concentration-dependent manner (Fig. 3A, Table 2 ). Amlodipine (10-1,000 nM) did not significantly affect thrombin-elicited Ca ] i values obtained at plateau (measured 3 min after thrombin stimulation) were 140 Ϯ 12, 146 Ϯ 36, 180 Ϯ 33, and 112 Ϯ 23 (SE) nM (n ϭ 5-9, not significant) for amlodipine additions of 0, 10, 100, and 1,000 nM, respectively. Under these experimental conditions, 100 nM isradipine did not significantly influence thrombininduced Ca 2ϩ responses (Table 2) ; diltiazem and verapamil behaved as isradipine (not shown). Experiments carried out in Ca 2ϩ -free medium (Fig. 3B, Table 2 ) confirmed that although 100 nM isradipine was without effect, amlodipine inhibited thrombin-induced Ca 2ϩ mobilization from internal stores in a concentration-dependent manner; they also revealed that as low as 10 nM amlodipine significantly reduced Ca 2ϩ mobilization by ϳ40-45% without modifying basal and plateau [Ca 2ϩ ] i values. To further characterize the origin of the internal Ca 2ϩ pool affected by amlodipine, VSMCs were pretreated for 2 h with diluent or 100 nM amlodipine (Fig.  4, traces a and (Fig. 5B) . Pretreatment of VSMCs with amlodipine for 2 h blunted the thapsigargin-evoked [Ca 2ϩ ] i increase in a concentration-dependent manner, irrespective of the presence of Ca 2ϩ in the extracellular medium (Fig. 5, Table 3 ). Thus as low as 1 nM amlodipine significantly reduced Values are means Ϯ SE; n, number of experiments. Values were measured at peak. They are expressed as ⌬[Ca 2ϩ ] i , i.e., after subtraction of the respective values measured before thrombin (1 U/ml) addition. Amlodipine was used at the various concentrations indicated. Isradipine was used at 100 nM. * P Ͻ 0.05 compared with values obtained in the absence of amlodipine. (by ϳ10-15%) the thapsigargin-induced Ca 2ϩ response (Table 3 ). In the absence of Ca 2ϩ in the extracellular medium, experiments with amlodipine at Ͻ100 nM could not be interpreted because of the weakness of the signal.
Effect of amlodipine on thrombin-induced
With use of a similar experimental protocol, treatment of VSMCs in a Ca 2ϩ -containing medium with 100 nM isradipine, diltiazem, or verapamil did not alter the thapsigargin-induced increase in [Ca 2ϩ ] i , since the percent inhibitions were 2 Ϯ 9, Ϫ16 Ϯ 19, and 8 Ϯ 6 (SE), respectively (n ϭ 5, not significant). Likewise, under these experimental conditions, the increase in [Ca Because mobilization of intracellular Ca 2ϩ stores often triggers store-operated Ca 2ϩ entry, in another set of experiments, we tested the possibility that amlodipine inhibited Ca 2ϩ entry after Ca 2ϩ store depletion. In these experiments, VSMCs were treated for 20 min with diluent or with 100 nM amlodipine (Fig. 6 , traces a and b, respectively) before stimulation by thapsigargin in Ca 2ϩ -free medium to deplete intracellular Ca 
, trace c). Kinetics of the inhibition by amlodipine of thrombinand thapsigargin-induced [Ca 2ϩ
] i increase. In the experiments presented above, amlodipine was always added 2 h before VSMC stimulation by thrombin or thapsigargin. We therefore studied the time dependence of amlodipine pretreatment on thrombin-or thapsigargin-induced [Ca 2ϩ ] i increases. The kinetics of action of amlodipine on thrombin-induced intracellular Ca 2ϩ mobilization were observed in Ca 2ϩ -free medium (Fig. 7A) . The kinetics of action of amlodipine on the thapsigargininduced increase in Ca 2ϩ were studied in Ca 2ϩ -containing medium (Fig. 7B) , because the amplitude of thapsigargin-induced [Ca 2ϩ ] i increase in Ca 2ϩ -free medium was too low (Fig. 5, Table 3 ). Nevertheless, Fig. 7 shows that the kinetics of action of amlodipine (100 nM) were similar, irrespective of stimulus. Thrombin-and thapsigargin-induced [Ca 2ϩ ] i increases were not significantly modified by the addition of amlodipine 10 min before VSMC stimulation but were almost maximally inhibited by pretreatment of VSMCs for 20 min with amlodipine.
DISCUSSION
The results reported here show that thrombin-induced Ca 2ϩ responses clearly consisted of two phases ( Fig. 1 ): 1) a transient Ca 2ϩ increase that corresponded to the mobilization of thapsigargin-sensitive intracellular Ca 2ϩ stores, i.e., those Ca 2ϩ ions that were sequestered in the sarcoplasmic reticulum and could be released by inositol trisphosphate (IP 3 ), and 2) a sustained Ca 2ϩ increase that corresponded to an influx that was not mediated by the voltage-operated channels ( Figs. 1 and 3; see below) . This is in agreement with previous reports (2, 26, 30, 41) . Figure 2 also demonstrates that, under our experimental conditions, VSMCs expressed functional L-type Ca 2ϩ channels, as expected (10) , and that amlodipine behaves as a CCB.
Treatment of VSMCs with amlodipine, but not with isradipine, before their stimulation with thrombin, affected in a concentration-dependent manner only that Ca 2ϩ response corresponding to mobilization from internal stores (Fig. 3, Table 2 ). Treatment of VSMCs with amlodipine, isradipine, diltiazem, or verapamil did not affect thrombin-induced Ca 2ϩ influx from external medium ( Fig. 3A; results not shown). Amlodipine behaved similarly in VSMCs isolated from human internal mammary artery and stimulated by thrombin (results not shown). However, amlodipine has no effect in vasopressin-stimulated A7r5 cells (16) . The intracellular Ca 2ϩ pool mobilized by thrombin and sensitive to amlodipine in a concentration-dependent manner has been identified as a thapsigargin-sensitive pool (Fig. 1 , B and C, and Figs. 4-6; see below). This is to our knowledge the first time that an L-type CCB has been shown to be capable of altering the Ca 2ϩ responses of VSMCs to thrombin. Nevertheless, neither amlodipine (Fig. 3A) , isradipine, diltiazem, nor verapamil could inhibit thrombin-induced Ca 2ϩ influx. This indicated that, although VSMCs did express functional L-type Ca 2ϩ channels, thrombin-induced Ca 2ϩ influx was not mediated by such voltage-operated channels, consistent with results reported 1) in neonatal rat VSMCs, where the Ca 2ϩ responses to thrombin were not affected by nicardipine or (ϩ)-BAY K 8644 inhibitor (26) , and 2) in the dog coronary artery, where the contractile response to thrombin was not affected by CCBs (12) .
In Ca 2ϩ -free medium, the addition of thapsigargin to VSMCs that had previously been stimulated by a maximal dose of thrombin induced a Ca 2ϩ response unless the cells had been pretreated with amlodipine (Fig. 4) . The additional Ca 2ϩ fraction mobilized by thapsigargin may be an IP 3 -insensitive Ca 2ϩ pool or a portion of the IP 3 -sensitive pool that is not mobilized by a maximum concentration of thrombin, as previously observed with endothelin (42) . Our finding is also consistent with the recent observation that IP 3 -induced Ca 2ϩ release reflects partial emptying of intracellular stores in A7r5 VSMCs (25) . That the pretreatment of VSMCs with amlodipine could completely blunt the effect of thapsigargin (Fig. 4) 1) demonstrated that the effects of amlodipine on thrombin-induced Ca 2ϩ responses could not be accounted for by an inhibition of thrombin binding to its membrane receptors and 2) indicated that amlodipine interfered with thapsigargin in a manner that prevents the Ca 2ϩ release. Our results also showed unambiguously that pretreatment of cells with amlodipine, but not with isradipine, diltiazem, or verapamil, inhibited in a concentration-dependent manner thapsigargin-induced Ca 2ϩ responses, irrespective of the presence of Ca 2ϩ in the external medium (Fig. 5, Table 3 ; data not shown). This confirmed the preceding observation and, in addition, demonstrated that amlodipine could not exert its effect through the inhibition of IP 3 binding to its receptors. Moreover, the kinetics of inhibition by amlodipine of thrombin-and thapsigargin-induced Ca 2ϩ responses were similar (Fig. 7) . Furthermore, the comparison of kinetics of inhibition by amlodipine of voltage-dependent Ca 2ϩ influx from the external medium and of thrombin/thapsigargin-induced Ca 2ϩ mobilization from internal stores clearly indicated that these effects of amlodipine are dissociated from each other.
Taken together, our results therefore suggest that the mechanism of action of amlodipine in thrombinand thapsigargin-induced Ca 2ϩ responses in VSMCs is similar and does not involve L-type Ca 2ϩ channel blockade. They led us to hypothesize that to interfere with thrombin-and thapsigargin-induced Ca 2ϩ mobilization from internal stores, amlodipine interacts directly or indirectly with the enzyme activities that are closely involved in the control of such a mobilization, namely, the SERCAs. Further observations are reported that support this hypothesis. 1) Amlodipine also inhibited Ca 2ϩ mobilization induced by BHQ, a compound that, like thapsigargin, is known to mobilize intracellular Ca 2ϩ stored in the sarcoplasmic reticulum, irrespective of the production of IP 3 , by inhibiting the SERCAs (19, 40, 42) .
2) The so-called store-operated Ca 2ϩ entry that participates in the sustained Ca 2ϩ response observed in thapsigargin-stimulated VSMCs and that is known to be closely linked to the filling state of internal Ca 2ϩ stores (14) was markedly Fig. 7 . Kinetics of the effect of amlodipine on thrombin-and thapsigargin-induced Ca 2ϩ responses. For the effects on thrombin (A) and thapsigargin (B), the experimental protocols were as described in the legends of Figs. 3B and 5A, respectively, except VSMCs were pretreated with amlodipine for the time indicated. Results (means Ϯ SE of 4 experiments) are expressed as percent inhibition of Ca 2ϩ increase that was determined at peak (A) and at plateau (B).
reduced in amlodipine-pretreated VSMCs (Figs. 5A  and 6 ). The store-operated Ca 2ϩ entry in VSMCs has been reported to be insensitive to nifedipine and nicardipine (42, 43) , consistent with our observations with isradipine, diltiazem, and verapamil. At variance, observations in guinea pig intestinal smooth muscle showed that the thapsigargin-evoked Ca 2ϩ increase and contraction were blocked by CCBs such as nimodipine and D-600 (5). On the other hand, an interaction between thapsigargin and the voltage-dependent Ca 2ϩ channel has been reported in the A7r5 cell line and in adrenal glomerulosa cells (3, 34) . Some specific structural characteristics of amlodipine (vs. other CCBs) have been envisaged to account for its antioxidant property (22) . One may hence speculate that such a structure might also confer on amlodipine a particular physicochemical interaction with the sarcoplasmic reticulum. Nevertheless, the mechanism of action of amlodipine and the modulation of SERCA activity by amlodipine remain to be proved.
In conclusion, the agent amlodipine was demonstrated to inhibit thrombin-and thapsigargin-induced Ca 2ϩ responses from intracellular Ca 2ϩ stores and thapsigargin-induced Ca 2ϩ influx from the external medium. The effects of amlodipine on thrombinand thapsigargin-evoked Ca 2ϩ responses appeared to be specific, since they could not be reproduced with isradipine, diltiazem, or verapamil. In rat aortic VSMCs, this is the first time that a CCB has been reported to alter Ca 2ϩ responses of VSMCs to thapsigargin and thrombin. Such findings might be related to the inhibitory potency of amlodipine on thrombin-induced VSMC growth (39), since SERCA inhibitors, including thapsigargin, cyclopiazonic acid, and BHQ, have been reported to inhibit serum-induced VSMC and DDT 1 MF-2 cell proliferation (8, 20, 36, 37) , in agreement with the concept that the intracellular Ca 2ϩ pool content is linked to control of cell growth (9, 21, 36) . In this respect, we have observed that amlodipine and thapsigargin similarly inhibited thrombin-induced DNA synthesis in cultured rat aortic VSMCs (results not shown). Furthermore, our findings might be of clinical relevance, since 10 nM amlodipine has been reported to correspond to the tissue concentration achieved after antihypertensive treatment of rats (28, 35) . One may therefore envisage that amlodipine effects on Ca 2ϩ movements participate in the antiatherogenic properties of this drug.
